human tgct embryonal carcinoma ec cell lines nt2 d1 (ATCC)
Structured Review

Human Tgct Embryonal Carcinoma Ec Cell Lines Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 136 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tgct embryonal carcinoma ec cell lines nt2 d1/product/ATCC
Average 95 stars, based on 136 article reviews
Images
1) Product Images from "Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors"
Article Title: Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors
Journal: Cancers
doi: 10.3390/cancers18040575
Figure Legend Snippet: Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
Techniques Used: Derivative Assay
Figure Legend Snippet: p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.
Techniques Used: Expressing, Activation Assay
![The post-mortem bipolar disorder (BD) gene expression dataset was created using RNA sequencing (RNAseq) data from post-mortem dorsolateral prefrontal cortex (DLPFC) samples obtained from BD patients and healthy controls (HC). This dataset was used to create gene regulatory networks, which were then compared to a list of genes related to melatonin synthesis, signalling, and degradation using gene set enrichment analysis (GSEA), and to gene regulatory networks for melatonin agonists. The <t>NT2-N</t> gene expression dataset was created using RNAseq libraries prepared from differentiated NT2-N neurons treated with various mood stabilisers for 24 hours. This dataset was then compared to a list of melatonin-related genes using GSEA. [Created by authors with biorender.com ]](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_28/10__1101_slash_2025__09__03__673928/10__1101_slash_2025__09__03__673928___F1.large.jpg)
